Lin Hou
Impact in
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery
- Biomedical Engineering top 1%
- Nanoplatforms for cancer theranostics
- Graphene and Nanomaterials Applications
Papers in
-
- Nanoplatforms for cancer theranostics 50
- Graphene and Nanomaterials Applications 20
- Biomaterials 32
- Nanoparticle-Based Drug Delivery 31
- Co-authors
- Zhenzhong Zhang (20 shared papers)Huijuan Zhang (28 shared papers)Hongling Zhang (17 shared papers)Huijuan Zhang (19 shared papers)Qianhua Feng (8 shared papers)Zhenzhong Zhang (8 shared papers)Wanxia Zhang (5 shared papers)Hongyu Zhao (2 shared papers)
- Journals
- ACS Applied Materials & Interfaces (7 papers)Journal of drug targeting (7 papers)Journal of Controlled Release (6 papers)Nanotechnology (4 papers)Acta Biomaterialia (4 papers)
- Partner nations
- ChinaUnited StatesNew Zealand
In The Last Decade
Lin Hou
88 papers receiving 4.4k citations
Peers
Comparison fields: 5 of 134
- Biomaterials 1.3k
- Biomedical Engineering 2.4k
- Immunology 922
- Pharmaceutical Science 219
- Molecular Medicine 117
Countries citing papers authored by Lin Hou
This map shows the geographic impact of Lin Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Hou more than expected).
Fields of papers citing papers by Lin Hou
This network shows the impact of papers produced by Lin Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Hou. The network helps show where Lin Hou may publish in the future.
Co-authors
The 25 scholars most cited alongside Lin Hou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 89 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 372 | |
| 2 | 2020 | 276 | |
| 3 | 2015 | 197 | |
| 4 | 2012 | 185 | |
| 5 | 2018 | 166 | |
| 6 | 2016 | 160 | |
| 7 | 2019 | 136 | |
| 8 | 2017 | 134 | |
| 9 | 2022 | 125 | |
| 10 | 2020 | 122 | |
| 11 | 2017 | 113 | |
| 12 | 2018 | 111 | |
| 13 | 2016 | 100 | |
| 14 | 2014 | 96 | |
| 15 | 2018 | 83 | |
| 16 | 2018 | 83 | |
| 17 | 2015 | 82 | |
| 18 | 2018 | 79 | |
| 19 | 2013 | 75 | |
| 20 | 2016 | 71 |
About Lin Hou
Lin Hou is a scholar working on Biomedical Engineering, Biomaterials, Materials Chemistry, Immunology and Molecular Biology, having authored 89 papers that have together received 4.4k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (50 papers), Nanoparticle-Based Drug Delivery (31 papers), Graphene and Nanomaterials Applications (20 papers), Immune cells in cancer (6 papers), Immunotherapy and Immune Responses (6 papers), Cancer, Hypoxia, and Metabolism (6 papers), Autophagy in Disease and Therapy (5 papers) and Extracellular vesicles in disease (5 papers). The work is most often cited by research in Biomaterials (1.3k citations), Biomedical Engineering (2.4k citations), Immunology (922 citations), Pharmaceutical Science (219 citations) and Molecular Medicine (117 citations). Lin Hou has collaborated with scholars based in China, United States and New Zealand. Frequent co-authors include Zhenzhong Zhang, Huijuan Zhang, Hongling Zhang, Huijuan Zhang, Qianhua Feng, Zhenzhong Zhang, Wanxia Zhang, Hongyu Zhao, Xiali Zhu and Zhenzhong Zhang. Their work appears in journals such as ACS Applied Materials & Interfaces, Journal of drug targeting, Journal of Controlled Release, Nanotechnology and Acta Biomaterialia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.